» Articles » PMID: 1900456

Cellular Immunity to HIV Activated by CD4 Fused to T Cell or Fc Receptor Polypeptides

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 1991 Mar 8
PMID 1900456
Citations 125
Authors
Affiliations
Soon will be listed here.
Abstract

We describe functional simplified T cell and Fc receptor chimeras that are capable of directing CD8+ cytotoxic T lymphocytes (CTLs) to specifically recognize and lyse cells expressing HIV envelope proteins. Target cells bearing HLA-DR molecules are not recognized by CTL armed with the chimeras. The variety of cell types in which the native receptors are active suggests multiple possibilities for antiviral intervention through genetic means.

Citing Articles

Cellular therapies in rheumatic and musculoskeletal diseases.

Franco-Fuquen P, Figueroa-Aguirre J, Martinez D, Moreno-Cortes E, Garcia-Robledo J, Vargas-Cely F J Transl Autoimmun. 2025; 10:100264.

PMID: 39931050 PMC: 11808717. DOI: 10.1016/j.jtauto.2024.100264.


From TCR fundamental research to innovative chimeric antigen receptor design.

Minguet S, Maus M, Schamel W Nat Rev Immunol. 2024; 25(3):212-224.

PMID: 39433885 DOI: 10.1038/s41577-024-01093-7.


Comparison of seven CD19 CAR designs in engineering NK cells for enhancing anti-tumour activity.

Wang Y, Li J, Wang Z, Liu Y, Wang T, Zhang M Cell Prolif. 2024; 57(11):e13683.

PMID: 38830795 PMC: 11533075. DOI: 10.1111/cpr.13683.


Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers.

Eichholz K, Fukazawa Y, Peterson C, Haeseleer F, Medina M, Hoffmeister S J Clin Invest. 2024; 134(7).

PMID: 38557496 PMC: 10977982. DOI: 10.1172/JCI169309.


CAR Immunotherapy for the treatment of infectious diseases: a systematic review.

Morte-Romea E, Pesini C, Pellejero-Sagastizabal G, Letona-Gimenez S, Martinez-Lostao L, Aranda S Front Immunol. 2024; 15:1289303.

PMID: 38352878 PMC: 10861799. DOI: 10.3389/fimmu.2024.1289303.